Pharmacogenomics Solutions
What if PGx had no limits?
Imagine a world in which pharmacogenomics research is faster, more flexible and more powerful – without being restricted by multiple workflows or costly, time-consuming processes.
Pharmacogenomics Solutions
What if PGx had no limits?
Imagine a world in which pharmacogenomics research is faster, more flexible and more powerful – without being restricted by multiple workflows or costly, time-consuming processes.
What if you could...
- • Perform single-nucleotide polymorphism, copy number variation and tandem repeat assays in a single qPCR workflow.
- • Get results in half the time.
- • 100% coverage of AMP Tier 1 CYP2D6 targets, including difficult-to-detect star alleles such as *29
Why choose the Advanta Pharmacogenomics Assay?
One workflow for everything
Perform SNP, CNV and tandem repeat analysis in a single, integrated qPCR workflow.
The Biomark™ system provides one workflow, one system
Example: Seamlessly detect key variants like UGT1A1 (rs3064744) and others.
Comprehensive CYP2D6 detection
We provide 100% AMP Tier 1 CYP2D6 coverage, detecting star alleles like *29 with unmatched precision.
Operational efficiency
With 1.6x lower sample requirements, your lab saves on reagents and costs while maximizing throughput.
Advanta PGx Core Panel
Core panel coverage
- Targets variants in 17 genes implicated in drug metabolism pathways
- Covers 71 SNPs/indels, three CNV markers and RNase P (control)
List of genes included in our assay
| Genes | SNP | CNV |
|---|---|---|
| CYP2D6 | 24 | 3 |
| CYP2C9 | 11 | |
| CYP2C19 | 10 | |
| CYP1A2 | 5 | |
| CYP3A5 | 4 | |
| CYP3A4 | 3 | |
| APOE | 2 | |
| MTHFR | 2 | |
| CYP2B6 | 2 | |
| SLCO1B1 | 1 |
| Genes | SNP | CNV |
|---|---|---|
| F5 | 1 | |
| ABCB1 | 1 | |
| OPRM1 | 1 | |
| COMT | 1 | |
| VKORC1 | 1 | |
| DRD2 | 1 | |
| F2 | 1 | |
| RNASE P | 1 | |
| Total | 71 | 4 |
| Genes | Alleles |
|---|---|
| CYP2D6 | *1, *2, *3, *4, *6, *7, *8, *9, *10, *11, *12, *14, *17, *19, *21, *30, *31, *33, *39, *40, *41, *42, *49, *56, *58, *59, *64, *65, *69, *104, *114, *119, *145, *147 |
| CYP2C9 | *1, *2, *3, *4, *5, *6, *8, *11, *12, *13, *15, *27 |
| CYP2C19 | *1, *2, *3, *4, *5, *6, *7, *9, *10, *17, *35 |
| CYP3A4 | *1, *2, *17, *22 |
| CYP3A5 | *1, *3, *3.010, *6, *7 |
| CYP2B6 | *1, *9, *18 |
| SLCO1B1 | *1, *5 |
| VKORC1 | *1, *2 |
Create a panel that meets your research needs, whether focused on drug response or rare variant detection.
| Gene/ Star Allele | Defining Variant rsIDs |
|---|---|
| NUDT15*2 | rs746071566 |
| NUDT15*6 | rs746071566 |
| NUDT15*9 | rs746071566 |
| UGT1A1*1 | rs3064744 |
| UGT1A1*28 | rs3064744 |
| Gene/ Star Allele | Defining Variant rsIDs |
|---|---|
| UGT1A1*36 | rs3064744 |
| UGT1A1*37 | rs3064744 |
| CYP3A4*20 | rs67666821 |
| CYP2D6*21 | rs67666821 |
Why choose our PGx solutions?
All-in-one flexibility
Whether using the predefined panel or designing a custom solution, our platform handles it all in a single workflow.
Future-proof your lab
Easily adapt to new guidelines, regulations and research needs by adding or modifying assays as required and leveraging the flexibility of our platform.
Comprehensive insights
With the most accurate and comprehensive detection of critical variants like CYP2D6, UGT1A1 and NUDT15, no other platform offers such precise pharmacogenomic insights in a single run.
Unlock the power of PGx without limits
For Research Use Only. Not for use in diagnostic procedures. Patent and License Information: www.standardbio.com/legal/notices. Trademarks: www.standardbio.com/legal/trademarks. Any other trademarks are the sole property of their respective owners. ©2025 Standard BioTools Inc. All rights reserved.